Home

Events

BioDefense Summit

Committees

Membership

Community

By-Laws

Links

 

 

BIO-SALSA MONTHLY MEETING

 

Friday, September 26, 2008  

 
 

Microencapsulation and Nanomaterials:

Life Science Programs at SwRI

 
 
SPEAKER:    Joe A. McDonough, Ph.D.
           Director, Microencapsulation, Nanomaterials, 
              Chemistry and Chemical Engineering Division
           Southwest Research Institute 
 
                                    
TIME:     7:30 AM    Registration and Breakfast 
	               8:00 AM    Meeting and Speaker Presentation
 
LOCATION:         
                              La Quinta Inn & Suites Conference Center-Medical Center 
                              4431 Horizon Hill Blvd. (I-10 East between Callaghan and Medical)
 
 
COST:     $15.00 SALSA members; $20.00 Non-members.  Exact change is appreciated. 
                              Checks payable to SALSA.  ($10.00 attendee fee without breakfast)
 

RSVP:     lkirk@incell.com or call 210.877.0100

 

About the Speaker:  Dr. McDonough is the director of Microencapsulation and Nanomaterials at SwRI in 
San Antonio. Most of his career has been spent in life sciences research to the extent that he has over 
18 years of experience managing R&D efforts in pharmaceutical development, including bulk and 
dosage-form development and manufacturing. The focus of his current work is on developing novel drug 
delivery technology.   Recently, he has developed a novel calcium phosphate nanoparticle system for small 
drug, iRNA and large protein delivery.  He is now leading efforts to confirm that this resorbable 
nanoparticle-based platform enhances antigen thermal stability and also provides adjuvant effects.  He is also 
the current program manager (PI), developing and cGMP manufacturing next generation organophosphate 
intoxication antidotes for the US Govt.  This involves synthesis, scale-up and formulation of a novel 
acetylcholinesterase reactivator (AChE).  He is also primarily responsible for the development of new 
muscarinic agonists that will be used with the new AChE reactivators that are used by the US military and 
first responders. He also oversees multiple SwRI programs (govt. and commercial), in ocular, nasal,  
transdermal, oral and intramuscular delivery, as well as wound and bone convalescence.  
 
About the Presentation: Dr McDonough will provide a brief overview of SwRI and its expertise in 
pharmaceutical development, micro- and nanoencapsulation.  He will then discuss and give an overview of 
various therapeutic based chem.- and biodefense projects and internal relevant research projects ongoing at 
SwRI.  Examples will include and cover synthesis, formulation and integrated device development.
 
This Month’s Breakfast Is Kindly Sponsored By SwRI

 

Please be a part of our great organization and contribute to

SALSA’s role in the future of our life science industry sector. 

www.bio-salsa.org

Interested in presenting, would like to recommend a speaker? Email:
mpmoyer@incell.com

 

    
(cash or checks only, Two-hours of parking is included.